Clinical Trial Update: Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluated safety, tolerability, and immunogenicity across three frozen ProQuad lot consistency lots in healthy children; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED | Results posted: 2010-02-09